Fig. 7
The concentration of Cre (a), the vitalities of ALT (b) and CK (c) in the serum, the RTv of different preparations at the treatment times (d), the RTv of different preparations at the end of the treatment (e), the RTw of different preparations at the end of the treatment (f), the isolated tumor tissues after being treated 12 days with different preparations (g), body weights of the tumor-bearing female BALB/c mice treated with different preparations at the treatment times (h), the body weights after being treated 12 days (i). A: N.S., B: Sal A solution, C: NLC-Sal A, D: DOX solution, E: DOX injection, F: Sal A/DOX solution, G: NLC-DOX, H: NLC-Sal A/DOX, I: E-[c(RGDfK)2]/FA-NLC-Sal A/DOX. **p < 0.01 vs DOX injection. *p < 0.05 vs DOX injection, **p < 0.01 vs DOX injection, ***p < 0.001 vs DOX injection, △p < 0.05 vs DOX solution, △△p < 0.01 vs DOX solution, △△△p < 0.001 vs DOX solution, ☆☆p < 0.01 vs NLC-DOX ☆☆☆p < 0.001 vs DOX-NLC, ##p < 0.01 vs Sal A/DOX-NLC. Results are expressed as mean ± SD, n = 6